Codes / ICD10CM / D05.01

D05.01 Lobular carcinoma in situ of right breast

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lobular carcinoma in situ of right breast
  • Often referred to as "LCIS of the right breast" or "lobular neoplasia of the right breast."

Summary

Lobular carcinoma in situ (LCIS) of the right breast is a non-invasive condition where abnormal cells are found in the lobules (milk-producing glands) of the right breast. It is not considered true cancer but indicates an increased risk of developing invasive breast cancer in either breast. LCIS is typically detected incidentally during a biopsy performed for another reason.

Causes

The exact cause of LCIS is not fully understood, but it involves genetic changes in the cells of the breast lobules. Hormonal factors and genetic predispositions may contribute to its development.

Risk Factors

  • Female gender, particularly premenopausal or perimenopausal women.
  • Family history of breast cancer.
  • Genetic mutations, such as in the BRCA1 or BRCA2 genes.
  • Prior history of benign breast conditions, like atypical lobular hyperplasia.

Symptoms

LCIS usually does not cause symptoms and is often found during a biopsy for an unrelated breast issue. Rarely, it may be associated with a lump or other breast changes, but these are uncommon.

Diagnosis

LCIS is diagnosed through a breast biopsy, typically performed after an abnormal finding on a mammogram, ultrasound, or MRI. A pathologist examines the tissue to confirm the presence of abnormal lobular cells.

Treatment Options

  • Active Surveillance: Regular monitoring with mammograms and clinical breast exams to detect changes early.
  • Risk-Reducing Medications: Tamoxifen or raloxifene may be prescribed to lower the risk of invasive breast cancer.
  • Prophylactic Surgery: Bilateral mastectomy (removal of both breasts) may be considered for high-risk individuals.

Prognosis and Follow-Up

LCIS itself does not typically progress to invasive cancer, but it increases the risk of developing invasive breast cancer in either breast. Follow-up care includes regular breast exams and imaging, with frequency determined by individual risk factors.

Complications

The primary complication is the increased risk of developing invasive breast cancer. LCIS does not usually cause physical symptoms or spread beyond the breast tissue.

Lifestyle & Prevention

  • Maintain a healthy weight and engage in regular physical activity.
  • Limit alcohol consumption.
  • Discuss family history and genetic testing with a healthcare provider to assess risk.

When to Seek Professional Help

Consult a healthcare provider if you notice new breast changes, such as a lump, skin changes, or nipple discharge, or if you have concerns about your breast cancer risk.

Tips for Medical Coders

Document the specific breast (right) and confirm the diagnosis is lobular carcinoma in situ. Ensure the code D05.01 is used when the condition is localized to the right breast and not generalized or unspecified. Include details about diagnostic methods (e.g., biopsy) and any associated risk factors if relevant to the clinical record.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

D05.01 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.